USA - NASDAQ:AUVI - US0379883004 - Common Stock
The current stock price of AUVI is 0.2926 USD. In the past month the price decreased by -50.28%. In the past year, price decreased by -99.38%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TT | TRANE TECHNOLOGIES PLC | 35.19 | 100.38B | ||
| JCI | JOHNSON CONTROLS INTERNATION | 30.07 | 74.58B | ||
| CARR | CARRIER GLOBAL CORP | 20.88 | 49.39B | ||
| LII | LENNOX INTERNATIONAL INC | 20.74 | 17.31B | ||
| ALLE | ALLEGION PLC | 20.47 | 14.16B | ||
| CSL | CARLISLE COS INC | 16.29 | 13.90B | ||
| MAS | MASCO CORP | 15.78 | 13.31B | ||
| BLDR | BUILDERS FIRSTSOURCE INC | 13.98 | 12.49B | ||
| WMS | ADVANCED DRAINAGE SYSTEMS IN | 23.93 | 10.73B | ||
| OC | OWENS CORNING | 8.37 | 10.34B | ||
| AOS | SMITH (A.O.) CORP | 17.25 | 9.21B | ||
| AWI | ARMSTRONG WORLD INDUSTRIES | 26.24 | 8.29B |
Applied UV Inc is a US-based company operating in Building Products industry. The company is headquartered in Mount Vernon, New York and currently employs 115 full-time employees. The company went IPO on 2020-08-27. Applied UV, Inc. is a sales and marketing company. The firm develops, acquires, markets, and sells surface and air disinfection technology focused on improving indoor air quality (IAQ), specialty LED lighting, luxury mirrors, and commercial furnishings, all of which serve clients globally in the healthcare, commercial & public venue, hospitality, food preservation, cannabis, education, and winery vertical markets. Its disinfectant segment is engaged in the design, manufacture, assembly, and distribution of a suite of air (fixed and mobile) and surface disinfecting systems for use in healthcare, hospitality, food preservation, education, and winery vertical markets. Its hospitality segment is engaged in the manufacture of fine mirrors and custom furniture specifically for the hospitality and retail industries. The firm has two wholly owned subsidiaries: SteriLumen, Inc., and Munn Works, LLC. SteriLumen owns and markets a portfolio of products with pathogen elimination technology.
APPLIED UV INC
150 N. Macquesten Pkwy
Mount Vernon NEW YORK 10550 US
CEO: Keyoumars Saeed
Employees: 115
Phone: 19292073751
Applied UV Inc is a US-based company operating in Building Products industry. The company is headquartered in Mount Vernon, New York and currently employs 115 full-time employees. The company went IPO on 2020-08-27. Applied UV, Inc. is a sales and marketing company. The firm develops, acquires, markets, and sells surface and air disinfection technology focused on improving indoor air quality (IAQ), specialty LED lighting, luxury mirrors, and commercial furnishings, all of which serve clients globally in the healthcare, commercial & public venue, hospitality, food preservation, cannabis, education, and winery vertical markets. Its disinfectant segment is engaged in the design, manufacture, assembly, and distribution of a suite of air (fixed and mobile) and surface disinfecting systems for use in healthcare, hospitality, food preservation, education, and winery vertical markets. Its hospitality segment is engaged in the manufacture of fine mirrors and custom furniture specifically for the hospitality and retail industries. The firm has two wholly owned subsidiaries: SteriLumen, Inc., and Munn Works, LLC. SteriLumen owns and markets a portfolio of products with pathogen elimination technology.
The current stock price of AUVI is 0.2926 USD. The price decreased by -8.56% in the last trading session.
AUVI does not pay a dividend.
AUVI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
The Revenue of APPLIED UV INC (AUVI) is expected to grow by 6.38% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
APPLIED UV INC (AUVI) has a market capitalization of 490.97K USD. This makes AUVI a Nano Cap stock.
You can find the ownership structure of APPLIED UV INC (AUVI) on the Ownership tab.
ChartMill assigns a fundamental rating of 1 / 10 to AUVI. AUVI may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months AUVI reported a non-GAAP Earnings per Share(EPS) of -14.68. The EPS decreased by -107.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.38% | ||
| ROE | -59.56% | ||
| Debt/Equity | 0.18 |
7 analysts have analysed AUVI and the average price target is 26.78 USD. This implies a price increase of 9050.72% is expected in the next year compared to the current price of 0.2926.
For the next year, analysts expect an EPS growth of 38.03% and a revenue growth 6.38% for AUVI